Lower 68 Ga-DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland-A proof-of-concept study.
Axel TjörnstrandOlivera Casar-BorotaKerstin HeurlingMichael SchöllPeter GjertssonJakob HimmelmanOleksiy ItsenkoOskar RagnarssonHelena Filipsson NyströmPublished in: Clinical endocrinology (2020)
This proof-of-concept study shows that 68 Ga-DOTATOC PET can be used to differentiate between normal pituitary tissue and NF-PitNET.